Atto Billio

2.3k total citations
37 papers, 840 citations indexed

About

Atto Billio is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Atto Billio has authored 37 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 17 papers in Pathology and Forensic Medicine and 14 papers in Immunology. Recurrent topics in Atto Billio's work include Lymphoma Diagnosis and Treatment (16 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Complement system in diseases (8 papers). Atto Billio is often cited by papers focused on Lymphoma Diagnosis and Treatment (16 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Complement system in diseases (8 papers). Atto Billio collaborates with scholars based in Italy, United States and Austria. Atto Billio's co-authors include E Bobbio-Pallavicini, Riccardo Centurioni, F Tacconi, Camillo Porta, L Gugliotta, E Ascari, Luigi Rigacci, Nicola Vianelli, Corrado Tarella and Antonio Pinto and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Atto Billio

36 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Atto Billio Italy	15	345	331	328	257	209	37	840
Charalampia Kyriakou United Kingdom	14	236 0.7×	469 1.4×	444 1.4×	323 1.3×	436 2.1×	64	1.0k
Masamitsu Karasawa Japan	17	249 0.7×	497 1.5×	210 0.6×	379 1.5×	99 0.5×	78	943
G. J. Ossenkoppele Netherlands	18	218 0.6×	309 0.9×	269 0.8×	135 0.5×	308 1.5×	51	832
Hilary K. Hargreaves United States	12	213 0.6×	135 0.4×	257 0.8×	110 0.4×	202 1.0×	15	689
Bouchra Asli France	15	206 0.6×	358 1.1×	71 0.2×	256 1.0×	125 0.6×	30	1.1k
Katsumichi Fujimaki Japan	19	153 0.4×	419 1.3×	303 0.9×	254 1.0×	330 1.6×	85	1.1k
Stefania Sacco Italy	13	264 0.8×	176 0.5×	134 0.4×	211 0.8×	50 0.2×	20	958
Ippei Miyagawa Japan	16	408 1.2×	120 0.4×	116 0.4×	114 0.4×	95 0.5×	72	904
Guillermo Debén Spain	15	101 0.3×	720 2.2×	258 0.8×	290 1.1×	244 1.2×	35	1.3k
Stéphanie Harel France	15	79 0.2×	315 1.0×	112 0.3×	276 1.1×	190 0.9×	51	785

Countries citing papers authored by Atto Billio

Since Specialization

Citations

This map shows the geographic impact of Atto Billio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atto Billio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atto Billio more than expected).

Fields of papers citing papers by Atto Billio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atto Billio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atto Billio. The network helps show where Atto Billio may publish in the future.

Co-authorship network of co-authors of Atto Billio

This figure shows the co-authorship network connecting the top 25 collaborators of Atto Billio. A scholar is included among the top collaborators of Atto Billio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atto Billio. Atto Billio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Palmieri, Raffaele, Atto Billio, Felicetto Ferrara, et al.. (2024). Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy. Frontiers in Oncology. 14. 1367393–1367393. 2 indexed citations

Mian, Michael, Luigi Marcheselli, Andrea Rossi, et al.. (2014). A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma. Annals of Oncology. 25(12). 2398–2404. 10 indexed citations

Tarella, Corrado, Luca Arcaini, Luca Baldini, et al.. (2014). Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation Guidelines for the Management of Indolent, Nonfollicular B-Cell Lymphoma (Marginal Zone, Lymphoplasmacytic, and Small Lymphocytic Lymphoma). Clinical Lymphoma Myeloma & Leukemia. 15(2). 75–85. 19 indexed citations

Cuneo, Antonio, Monia Marchetti, Giovanni Barosi, et al.. (2014). Appropriate use of bendamustine in first-line therapy of chronic lymphocytic leukemia. Recommendations from SIE, SIES, GITMO Group. Leukemia Research. 38(11). 1269–1277. 11 indexed citations

Corradini, Paolo, Monia Marchetti, Giovanni Barosi, et al.. (2014). SIE-SIES-GITMO Guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias. Annals of Oncology. 25(12). 2339–2350. 7 indexed citations

Barosi, Giovanni, Giampaolo Merlini, Atto Billio, et al.. (2012). SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma. Annals of Hematology. 91(6). 875–888. 23 indexed citations

Mauro, Francesca Romana, Giuseppe Bandini, Giovanni Barosi, et al.. (2011). SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia. Leukemia Research. 36(4). 459–466. 6 indexed citations

Laszlò, Daniele, Giovanna Andreola, Luigi Rigacci, et al.. (2010). Rituximab and Subcutaneous 2-Chloro-2′-Deoxyadenosine Combination Treatment for Patients With Waldenström Macroglobulinemia: Clinical and Biologic Results of a Phase II Multicenter Study. Journal of Clinical Oncology. 28(13). 2233–2238. 41 indexed citations

Santini, Valeria, P Alessandrino, Emanuele Angelucci, et al.. (2010). Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines. Leukemia Research. 34(12). 1576–1588. 81 indexed citations

10.

Morello, Enrico, Léonardo Pagani, Irene Cavattoni, et al.. (2010). Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study. Bone Marrow Transplantation. 46(1). 132–136. 12 indexed citations

11.

Rabascio, Cristina, Daniele Laszlò, Giovanna Andreola, et al.. (2009). Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenström's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chloro-2′-deoxyadenosine (2-CdA) and Rituximab. Leukemia Research. 34(4). 454–457. 9 indexed citations

12.

Cortelazzo, Sergio, Atto Billio, Alessandro Rambaldi, et al.. (2007). A GITIL Prospective Randomized Multicenter Phase III Study of High Dose Sequential Chemotherapy with Rituximab (R-HDS) and Autologous Transplantation (ASCT) of Peripheral Blood Stem Cells Versus CHOP and Rituximab Delivered Every 14 Days (R-CHOP-14) in High-Risk Patients with Diffuse Large B-Cell Lymphomas (DLBCL): Interim Analysis on Feasibility and Toxicity (Protocol R-HDS 0305).. Blood. 110(11). 1898–1898.

13.

Cecchi, Paolo, et al.. (2007). Primary high-grade B-cell lymphoma of the choroid plexus. Clinical Neurology and Neurosurgery. 110(1). 75–79. 19 indexed citations

14.

Cortelazzo, Sergio, Michele Magni, Corrado Tarella, et al.. (2007). Update of a GITIL Cohort Study: Frontline High Dose Sequential Chemotherapy with Rituximab and Autologous Stem Cell Transplantation Induces a High Rate of Long-Term Remissions in Patients with Mantle Cell Lymphoma. Blood. 110(11). 1282–1282. 4 indexed citations

15.

Laszlò, Daniele, Cristina Rabascio, Giovanna Andreola, et al.. (2007). Expression of the Human Concentrative Nucleotide Transporter (hCNT1) Gene Correlates with Clinical Response in Patients Affected by Waldenstrom’s Macroglobulinemia (WM), Undergoing a Combination Treatment with Cladribine (2-CdA) and Rituximab.. Blood. 110(11). 1357–1357. 3 indexed citations

16.

Billio, Atto, et al.. (2006). A case of relapsed meningeal Burkitt's leukemia/lymphoma treated with intraventricular rituximab combined with high‐dose cytarabine. American Journal of Hematology. 81(10). 798–799. 1 indexed citations

17.

Billio, Atto, et al.. (2002). A further case of acute myeloid leukaemia with inv(8)(p11q13) and MOZ-TIF2 fusion.. PubMed. 87(5). ECR15–ECR15. 6 indexed citations

18.

Billio, Atto, Norbert Pescosta, Giovanni Franco Zanon, et al.. (2001). Treatment of Kasabach-Merritt syndrome by embolisation of a giant liver hemangioma. American Journal of Hematology. 66(2). 140–141. 14 indexed citations

19.

Porta, Camillo, et al.. (1996). Thrombotic Thrombocytopenic Purpura and Relapes: Why do case series differ?. American Journal of Hematology. 52(3). 215–216. 1 indexed citations

20.

Bobbio-Pallavicini, E, Camillo Porta, Riccardo Centurioni, et al.. (1994). Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma‐exchange. European Journal Of Haematology. 52(4). 222–226. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact